• Login
    View Item 
    •   Home
    • UA Graduate and Undergraduate Research
    • UA Theses and Dissertations
    • Dissertations
    • View Item
    •   Home
    • UA Graduate and Undergraduate Research
    • UA Theses and Dissertations
    • Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UA Campus RepositoryCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsPublisherJournalThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsPublisherJournal

    My Account

    LoginRegister

    About

    AboutUA Faculty PublicationsUA DissertationsUA Master's ThesesUA Honors ThesesUA PressUA YearbooksUA CatalogsUA Libraries

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Preformulation and formulation studies of RH1: A new investigational anti-tumor agent

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    azu_td_3023506_sip1_m.pdf
    Size:
    1.308Mb
    Format:
    PDF
    Download
    Author
    Jain, Neera
    Issue Date
    2001
    Keywords
    Health Sciences, Pharmacology.
    Health Sciences, Pharmacy.
    Advisor
    Yalkowsky, Samuel H.
    
    Metadata
    Show full item record
    Publisher
    The University of Arizona.
    Rights
    Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.
    Abstract
    Currently, the National Cancer Institute is investigating RH1 for its potential use as an anti-tumor agent. A parenteral formulation is desired but the drug is highly unstable in aqueous solutions. Various effects on the stability of RH1 are investigated. All the reactions of RH1 follow first-order kinetics. The maximum shelf-life, obtained in neutral conditions, is about one week. The pH-rate profile shows slopes of approximately -1 in acidic conditions and +1 in basic conditions indicating that the degradation of RH1 is specific acid-base catalyzed. The energies of activation at pH's 6.0 and 7.0, and 8.0 confirm a difference in the mechanisms of decomposition in acid and base. No significant effect of light or anti-oxidants is seen in either acidic or basic solutions, however, the chelating agent (EDTA) significantly slows the degradation of RH1. Use of pure ethanol increased the stability four times that over the buffered solution at pH 7.33 resulting in a shelf-life of approximately one month. Four major degradation products are observed in acid pH. The results of LC-MS suggests that the degradation of RH1 involves hydrolysis of the aziridine rings to form the mono-ethanolamine derivative (degradation product I). The second reaction involves nucleophilic substitution of the aziridine ring(s) by hydroxyl groups to form mono-hydroxy derivatives. Depending upon which aziridine ring is hydrolyzed, two additional degradation product (II and III) can be formed. Two isomers are possible for the three proposed decomposition products. The absence of any degradation products with molecular masses expected from the reaction of both the aziridines suggests that one of the isomers is preferentially formed. This is most likely due to the fact that the C2 aziridine nitrogen can form a hydrogen bond with the neighboring methyl hyroxy group, making it less reactive. A freeze-dried formulation buffered at pH 7.0 containing 5% hydroxypropyl-beta-cyclodextrin that can be reconstituted with a buffer (pH 7.0) is recommended for parenteral use. A prodrug, 2,5-diaziridinyl-3,6-dihydroxymethyl-1,4-benzoquinone, is proposed based upon the fact that two hydrogen bonds between the hydroxymethyl groups and aziridine nitrogens will be possible that may lead to improved stability of the drug.
    Type
    text
    Dissertation-Reproduction (electronic)
    Degree Name
    Ph.D.
    Degree Level
    doctoral
    Degree Program
    Graduate College
    Pharmaceutical Sciences
    Degree Grantor
    University of Arizona
    Collections
    Dissertations

    entitlement

     
    The University of Arizona Libraries | 1510 E. University Blvd. | Tucson, AZ 85721-0055
    Tel 520-621-6442 | repository@u.library.arizona.edu
    DSpace software copyright © 2002-2017  DuraSpace
    Quick Guide | Contact Us | Send Feedback
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.